Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Health Catalyst (HCAT) Shares Issued (2018 - 2026)

Health Catalyst filings provide 9 years of Shares Issued readings, the most recent being $403000.0 for Q1 2026.

On a quarterly basis, Shares Issued fell 42.01% to $403000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.2 million, a 5700.0% increase, with the full-year FY2025 number at $1.5 million, up 793.49% from a year prior.
Shares Issued hit $403000.0 in Q1 2026 for Health Catalyst, up from -$27000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $2.3 million in Q3 2023 to a low of -$1.3 million in Q3 2024.
Median Shares Issued over the past 5 years was $561000.0 (2024), compared with a mean of $551437.5.
The widest YoY moves for Shares Issued: up 245.88% in 2024, down 154.66% in 2024.
Health Catalyst's Shares Issued stood at $595000.0 in 2022, then plummeted by 35.8% to $382000.0 in 2023, then crashed by 430.37% to -$1.3 million in 2024, then soared by 97.86% to -$27000.0 in 2025, then skyrocketed by 1592.59% to $403000.0 in 2026.
The last three reported values for Shares Issued were $403000.0 (Q1 2026), -$27000.0 (Q4 2025), and $534000.0 (Q3 2025) per Business Quant data.